Healthcare

Shield Bio

Website

Shield Bio is a precision medicine company with a proprietary platform that enables reliable nanopore sequencing in under a minute, in a clinical setting. It is focused on bringing 3rd generation or "nanopore" sequencing into clinical use to deliver on the promise of precision medicine. Shield is initially using the technology to improve the

Overview

Shield Bio is a precision medicine company with a

proprietary platform that enables reliable nanopore

sequencing in under a minute, in a clinical setting. It is

focused on bringing 3rd generation or "nanopore"

sequencing into clinical use to deliver on the promise of

precision medicine. Shield is initially using the technology to

improve the treatment of infectious disease and address the

unmet clinical need of sepsis, which kills 300,000 people a

year in the US alone.

Company description As recorded 2026-11-08

Founders & team

Previously TL Biolabs, Shield Diagnostics

Company history As recorded 2026-11-08
28team members reported
Source-reported As recorded 2026-09-15

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA; San Jose, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The source reports an inactive or acquired company; current product identity needs review.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced people